(Nebraska Examiner) The University of Nebraska Medical Center is among more than 60 sites nationally that has been tapped for a trial study of a monkeypox treatment. The STOMP (Study of Tecovirimat for Human Monkeypox Virus) is a phase 3 trial evaluating the safety and effectiveness of the antiviral tecovirimat drug.
Fair Use Notice
UNMC Global Center for Health Security staff curate publicly available news and information for educational and informational purposes. Brief excerpts of published articles may be displayed under principles of Fair Use, with credit and links provided to the source publications. All copyrights remain the property of their respective owners.